Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Bart J. Biemond, MD PhD, Anil Tombak, MD, Yurdanur Kilinc, MD, Murtadha Al-Khabori, MD, Miguel R. Abboud, MD, Mohammed Nafea, MD, Adlette Inati, MD, Yasser Ahmed Mohamed Soliman Wali, MD, Jens Kristensen, MD PhD, Ellen Donnelly, PhD, John Ohd, MD PhD

Blood (2019) 134 (Supplement_1): 614.

https://doi.org/10.1182/blood-2019-124653

Published: 2019

Journal Articles

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Miranda Bailey, Megan Gibbs, Nidhi Dani, Ari Mendell, Melissa Thompson

Blood (2019) 134 (Supplement_1): 5867.

https://doi.org/10.1182/blood-2019-131699

Published: 2019

Journal Articles

Sickle Cell Disease Burden in North Lebanon

Adlette Inati, MD, Chadi Al Alam, Cristel El Ojaimi, Taghrid Hamad, Hemanth Kanakamedala, Virginia Pilipovic, Ramzieh Sabah

Blood (2019) 134 (Supplement_1): 1022.

https://doi.org/10.1182/blood-2019-128311

Published: 2019

Journal Articles

2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 β-Thalassemia Patient Cells: A Foundation for Potential Therapies

Blood (2019) 134 (Supplement_1): 2244.

https://doi.org/10.1182/blood-2019-127017

Published: 2019

Journal Articles

Better Outcome in Children Compared to AYAs and Young Adults after Allogeneic HSCT for AML: A Multicenter Retrospective Study from the Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM -TC)

Cecile Pochon, MD, Marie Y Detrait, MD, Jean-Hugues Dalle, MD PhD, Gerard Michel, MD, Mauricette Michallet, MD PhD, Yves Bertrand, MD, Didier Blaise, Ibrahim Yakoub-Agha, MD PhD, Jacques-Olivier Bay, MD PhD, Mohamad Mohty, MD PhD, Noel-Jean Milpied, MD, Patrice Chevallier, MD, Ali Bazarbachi, MD PhD, Yves Chalandon, MD PhD, Yves Beguin, MD PhD, Stephanie Ngoc Nguyen, Regis Peffault De Latour, Eliane Albuisson, Marie Thérèse Rubio, MD

Blood (2018) 132 (Supplement 1): 3449.

https://doi.org/10.1182/blood-2018-99-110209

Published: 2018

Journal Articles

Mediastinal Mass, Triglycerides Level Above 1000mg/Dl and Intensive Dexamethasone and Asparaginase Treatment Are Risk Factors for Cerebral Sinus Venous Thrombosis in Children Treated for Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon

Habib El-Khoury, B.Sc., MD Candidate, Khaled M Ghanem, MD, Yaacoub Mubarak, Nidale Tarek, MD, Hassan El Solh, Anthony K.C. Chan, MBBS, Carole Aridi, Miguel R. Abboud, Raya Saab, MD, Samar A. Muwakkit, MD

Blood (2018) 132 (Supplement 1): 5163.

https://doi.org/10.1182/blood-2018-99-119638

Published: 2018

Journal Articles

Decreasing Dose and Duration of Dexamethasone Therapy for Low-Risk Childhood Acute Lymphoblastic Leukemia Aiming to Avoid Serious Viral Infections Results in Significant Increase in Isolated CNS Relapse: A Prospective Study

Khaled M Ghanem, MD, Miguel R Abboud, MD, Nidale Tarek, MD, Raya Saab, MD, Hani Tamim, PhD, Hassan El-Solh, MD, Samar A. Muwakkit, MD

Blood (2017) 130 (Supplement 1): 1284.

https://doi.org/10.1182/blood.V130.Suppl_1.1284.1284

Published: 2017

Journal Articles

Consolidation with Bortezomib, Lenalidomide and Dexamethasone Upgrades the Complete Remission Rate after Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma

Iman Aboudalle, MD, Basel Haffar, MD, Radwan Massoud, MD, Ali Bazarbachi, MD PhD, Jean Elcheikh, MD

Blood (2017) 130 (Supplement 1): 1821.

https://doi.org/10.1182/blood.V130.Suppl_1.1821.1821

Published: 2017

Journal Articles

Interim Disease Evaluation Post Induction Chemotherapy for Acute Myeloid Leukemia

Nour Moukalled, Radwan Massoud, MD, Rami Mahfouz, MD, Zaher Chakhachiro, MD, Samer Nassif, MD, Jean Elcheikh, MD, Ali Bazarbachi, MD PhD

Blood (2017) 130 (Supplement 1): 5022.

https://doi.org/10.1182/blood.V130.Suppl_1.5022.5022

Published: 2017

Journal Articles

Quality of Life in Patients with β-Thalassemia: Transfusion Dependent Versus Non-Transfusion Dependent

Maria Domenica Cappellini, MD, Antonis Kattamis, MD, Vip Viprakasit, MD PhD, Pranee Sutcharitchan, MD, Dalia Mahmoud, Joseph Pariseau, PharmD, Abderrahmane Laadem, MD, Anzalee Khan, PhD, X. Henry Hu, MD PhD, Ali Taher, MDPhDFRCP

Blood (2017) 130 (Supplement 1): 751.

https://doi.org/10.1182/blood.V130.Suppl_1.751.751

Published: 2017

Journal Articles

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Amanda Chidiac, Radwan Massoud, MD, Mohamad Haidar, Elie Fares, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD

Blood (2016) 128 (22): 5357.

https://doi.org/10.1182/blood.V128.22.5357.5357

Published: 2016

Journal Articles

Bendamustine Demonstrates Promising Activity in Post-Brentuximab Failure Hodgkin Lymphoma Patients Who Had Also Failed a Prior Autologous HCT and Facilitates Successful Bridging to Allogeneic HCT

Jean Elcheikh, MD, Radwan Massoud, MD, Elie Fares, Mohamed A Kharfan-Dabaja, MD, Jisr Tamima, MD, Anas Mougharbel, MD, Ali Bazarbachi, MD PhD, Ahmad Ibrahim

Blood (2016) 128 (22): 5359.

https://doi.org/10.1182/blood.V128.22.5359.5359

Published: 2016

Journal Articles

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Ali Amid, MD, Rebecca Leroux, BScN, Manuela Merelles-Pulcini, MSc, Saeed Yassobi, MD, Antoine N Saliba, MD, Richard Ward, MSc, MRCP, FRCPath, Mehran Karimi, MD, Ali T. Taher, MD PhD, Robert J Klaassen, MD, Melanie Kirby-Allen, MD

Blood (2016) 128 (22): 3633.

https://doi.org/10.1182/blood.V128.22.3633.3633

Published: 2016

Journal Articles

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Timothy P. Hughes, MD, Eduardo Ciliao Munhoz, MD, Alaa Elhaddad, MD PhD, Ong Tee Chuan, MD, Kudrat Abdulkadyrov, MD, Jake Shortt, MD, Hang Quach, MD FRACP, FRCPA, MBBS, Carolina Pavlovsky, MD, Vernon J. Louw, MBChB, M.MD FCP(SA), PhDHPE), Luis Meillon, MD, Lee-Yung Shih, MD Professor, Anna G. Turkina, MD PhD, Jonathan Hwang, PharmD, MBA, Prasanna Kumar Nidamarthy, Darshan Dalal, MD PhD MPH, Jeffrey H. Lipton, PhD MD

Blood (2014) 124 (21): 4542.

https://doi.org/10.1182/blood.V124.21.4542.4542

Published: 2014

Journal Articles

G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis

Ahmad Antar, MD, Zaher Otrock, MD, Mohamed Kharfan-Dabaja, MD, Hussein Abou Ghaddara, MD, Nabila Kreidieh, CLS, Rami Mahfouz, MD MPH, Ali Bazarbachi, MD PhD

Blood (2014) 124 (21): 5823.

https://doi.org/10.1182/blood.V124.21.5823.5823

Published: 2014

Journal Articles

Genetic Polymorphisms In Candidate Genes Predict Increased Toxicity With Methotrexate Therapy In Children With Acute Lymphoblastic Leukemia In Lebanon

Nathalie K Zgheib, MD, Maya Akra-Ismail, Carol Aridi, MD, Rami Mahfouz, MD, MPH, Raya Saab, MD, Miguel R. Abboud, MD, MHA, Hassan Solh, MD, Samar A. Muwakkit, MD

Blood (2013) 122 (21): 4926.

https://doi.org/10.1182/blood.V122.21.4926.4926

Published: 2013

Journal Articles

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Adlette Inati, MD, Javid Gaziev, MD, Hussein A Abbas, PhD, Serge Korjian, BSc, Yazan Daaboul, BSc, Mario Kahale, MD, Katia Paciaroni, MD, Gioia de Angelis, MD, Ali T Taher, MD, Therese Abi Nasr, MD, Suzan Koussa, MD, Guido Lucarelli, MD

Blood (2013) 122 (21): 5505.

https://doi.org/10.1182/blood.V122.21.5505.5505

Published: 2013

Journal Articles

A Multicenter Study On Hereditary Spherocytosis In Lebanon

Adlette Inati, MD, Peter Noun, MD, Nabil Kabbara, MD, Cynthia Salloum, MD, Michel Kmeid, MD, Maroun Sadek, MD, Mario Kahale, MD, Hussein A Abbas, PhD

Blood (2013) 122 (21): 4661.

https://doi.org/10.1182/blood.V122.21.4661.4661

Published: 2013

Journal Articles

Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients

Jennifer Alison Busse, CNP, MPH, Kranthi Nandan Seelaboyina, MBBS, Grace Malonga, MPH, Madhuri Jakkam Setty, MBBS, Thomas Moulton, MD

Blood (2013) 122 (21): 4677.

https://doi.org/10.1182/blood.V122.21.4677.4677

Published: 2013

Journal Articles

A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients

Jennifer Alison Busse, CNP, MPH, Kranthi Nandan Seelaboyina, MBBS, Grace Malonga, MPH, Thomas Moulton, MD

Blood (2013) 122 (21): 1723.

https://doi.org/10.1182/blood.V122.21.1723.1723

Published: 2013

NARROW

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Sickle Cell Disease Burden in North Lebanon

2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 β-Thalassemia Patient Cells: A Foundation for Potential Therapies

Better Outcome in Children Compared to AYAs and Young Adults after Allogeneic HSCT for AML: A Multicenter Retrospective Study from the Societe Francophone De Greffe De Moelle Et De Therapie Cellulaire (SFGM -TC)

Mediastinal Mass, Triglycerides Level Above 1000mg/Dl and Intensive Dexamethasone and Asparaginase Treatment Are Risk Factors for Cerebral Sinus Venous Thrombosis in Children Treated for Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon

Decreasing Dose and Duration of Dexamethasone Therapy for Low-Risk Childhood Acute Lymphoblastic Leukemia Aiming to Avoid Serious Viral Infections Results in Significant Increase in Isolated CNS Relapse: A Prospective Study

Consolidation with Bortezomib, Lenalidomide and Dexamethasone Upgrades the Complete Remission Rate after Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma

Interim Disease Evaluation Post Induction Chemotherapy for Acute Myeloid Leukemia

Quality of Life in Patients with β-Thalassemia: Transfusion Dependent Versus Non-Transfusion Dependent

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Bendamustine Demonstrates Promising Activity in Post-Brentuximab Failure Hodgkin Lymphoma Patients Who Had Also Failed a Prior Autologous HCT and Facilitates Successful Bridging to Allogeneic HCT

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis

Genetic Polymorphisms In Candidate Genes Predict Increased Toxicity With Methotrexate Therapy In Children With Acute Lymphoblastic Leukemia In Lebanon

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

A Multicenter Study On Hereditary Spherocytosis In Lebanon

Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients

A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only